Antidepressive Agents
Research News and Information

Saturday, November 21, 2009

Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.

30 Oct 2009 CONTEXT: Previous studies have found that few chronically depressed patients remit with antidepressant medications alone. OBJECTIVE: To determine the role of adjunctive psychotherapy in the treatment of chronically depressed patients with less than ... Read more...

Bipolar II postpartum depression: Detection, diagnosis, and treatment.

30 Oct 2009 Research on postpartum mood disorders has focused primarily on major depressive disorder, bipolar I disorder, and puerperal psychosis and has largely ignored or neglected bipolar II disorder. Hypomanic symptoms are common after delivery but ... Read more...

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

19 Oct 2009 CONTEXT: Studies of depressed psychiatric patients have shown that antidepressant efficacy can be increased by augmentation with omega-3 fatty acids. OBJECTIVE: To determine whether omega-3 improves the response to sertraline in patients with major ... Read more...

Latest indexed articles for 'Antidepressive Agents'

These are the very latest articles for this heading:

• Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. 30 Oct 2009
• Bipolar II postpartum depression: Detection, diagnosis, and treatment. 30 Oct 2009
• SSRIs and congenital defects. Spontaneous publishing and academic miscarriages (SPAM). 19 Oct 2009
• Women should give informed consent before starting SSRIs. 19 Oct 2009
• SSRIs and congenital defects. Case registers in pregnancy? 19 Oct 2009
• Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. 19 Oct 2009
• Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. 13 Oct 2009
• [Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices] 3 Oct 2009
• Treating premenstrual dysphoric disorder. Options include drugs targeting serotonin and various types of hormone therapy. 29 Sep 2009
• Tamoxifen, antidepressants, and CYP2D6: the conundrum continues. 29 Sep 2009
• Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. 29 Sep 2009
• Incremental benefit and cost of telephone care management and telephone psychotherapy for depression in primary care. 29 Sep 2009
• Antidepressant use and preterm birth. 29 Sep 2009
• Rapid improvement in affective information processing after acute administration of reboxetine. 29 Sep 2009
• Treatment of neuropathic pain: an overview of recent guidelines. 29 Sep 2009
• Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice. 24 Sep 2009
• Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats. 24 Sep 2009
• Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. 21 Sep 2009
• Selective serotonin reuptake inhibitors and congenital malformations. 21 Sep 2009
• Antidepressant actions of histone deacetylase inhibitors. 14 Sep 2009

See a longer list of these articles.

Technical information about 'Antidepressive Agents'

Definition: Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Registry Number: 0

Descriptor UI: D000928

Alternative terms: Antidepressive Agents; Agents, Antidepressive; Antidepressant Drugs; Drugs, Antidepressant; Antidepressants; Thymoleptics; Thymoanaleptics;

Related Mesh Headings: Monoamine Oxidase Inhibitors;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.427.700.122;

Online Note: use ANTIDEPRESSIVE AGENTS to search PSYCHIC ENERGIZERS 1966-94; use ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS to search THYMOLEPTICS 1969-78

History Note: 66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78

Technical Notes: GEN or unspecified; prefer specific groups or specific antidepressive agents; consider also DEPRESSION /drug ther